ℹ️
🇬🇧
Search
Search for publications relevant for "low-dose dexamethasone"
low-dose dexamethasone
Publication
Class
Person
Publication
Programmes
publication
Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer
2003 |
First Faculty of Medicine
publication
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
2019 |
First Faculty of Medicine
publication
Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer
2003 |
Faculty of Medicine in Hradec Králové
publication
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
2022 |
First Faculty of Medicine
publication
Bi.weekly eipirubicin and etoposide plus low dose dexamethasone (EED) for hormone-refractory prostate cancer (HRPC)
Publication without faculty affiliation
publication
Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia
2014 |
Faculty of Medicine in Pilsen, Second Faculty of Medicine
publication
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma
2016 |
Faculty of Medicine in Hradec Králové
publication
Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
2018 |
First Faculty of Medicine
publication
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
2015 |
Faculty of Medicine in Hradec Králové
publication
Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
2018 |
First Faculty of Medicine
publication
Short-term exercise combined with Acipimox administration induces an increase in plasma ACTH and its subsequent fall in the recovery phase in bulimic women
2013 |
First Faculty of Medicine
publication
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma
2016 |
Publication without faculty affiliation
publication
Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
2021 |
First Faculty of Medicine
publication
Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN
2017 |
Third Faculty of Medicine